Rights Issue28 Apr 2026, 05:23 pm
Indrayani Biotech Committee Approves Rights Issue Documents
AI Summary
Indrayani Biotech Ltd's Rights Issue Committee, at its meeting on April 28, 2026, approved crucial documents for the proposed Rights Issue. The approvals include the Letter of Offer (LOF), the Abridged Letter of Offer (ALOF), and the Composite Application Form (CAF). Additionally, the committee sanctioned the detailed instructions for the renunciation process. This development signifies progress in the company's efforts to proceed with its capital raising initiative through a Rights Issue.
Key Highlights
- Rights Issue Committee met on April 28, 2026.
- Approved Letter of Offer (LOF) and Abridged LOF.
- Approved Composite Application Form (CAF) format.
- Detailed instructions for renunciation process also approved.
Price Impact
More from INDRANIB